Richard Price, MD
Professor Emeritus
Neurology
School of Medicine

Grants and Projects

Show all (21) Hide

• Compartmentalized CSF viral escape and the CNS HIV reservoir, NIH, 2015-2021
• HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation, NIH, 2011-2016
• Central Nervous System HIV Translational Research Training Program, NIH, 2010-2015
• The Neuropathobiology of Primary HIV-1 Infection, NIH, 2008-2015
• Defining CNS HIV Infection in Treated Patients: Foundation for Eradication, NIH, 2012-2014
• HIV Proteomic Center for Host-Viral Response Characterization, NIH, 2008-2012
• CSF &Lymphocyte Dynamics in HIV Infection, NIH, 2000-2011
• Pilot Study of Treatment Augmentation on CNS Immunoactivation in Treated HIV-1 In, NIH, 2008-2011
• Drug Abuse Treatment System Survey, NIH, 1983-2008
• CSF Molecular Marker Study Consortium, NIH, 2002-2008
• General Clinical Research Center, NIH, 1974-2007
• Treatment&Pathogenesis of Cerebrospinal Fluid HIV Infect, NIH, 1998-2006
• Michigan Prevention Research Center, NIH, 1989-2004
• Neurologic Aids Research Consortium, NIH, 1993-2003
• Hereditary Ataxia--Molecular Genetics &Pathophysiology, NIH, 1995-2000
• Preventing Depression in Couples Facing Job Loss, NIH, 1994-2000
• AIDS DEMENTIA COMPLEX, NIH, 1988-1999
• Michigan Prevention Research Center, NIH, 1983-1994
• HIV, AIDS AND THE BRAIN, NIH, 1992-1993
• Regional Brain Metabolism in Viral Encephalitis, NIH, 1983-1989
• AIDS DEMENTIA, NIH, 1985-1988

Publications (217)

Top publication keywords:
NeopterinCerebrospinal FluidAnti-Retroviral AgentsHIV-1Nervous System DiseasesAntiretroviral Therapy, Highly ActiveAcquired Immunodeficiency SyndromeRNA, ViralHIV InfectionsAIDS Dementia ComplexViral LoadCentral Nervous SystemAnti-HIV AgentsNeurofilament ProteinsBlood-Brain Barrier

• Reply to 'Cognitive criteria in HIV: greater consensus is needed'.
  Nature reviews. Neurology 2024 Nightingale S, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Saylor D, Thomas KGF, Underwood J, Vera JH, Winston A
• Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia.
  AIDS (London, England) 2023 Mastrangelo A, Scotti GM, Manteiga JG, Gisslén M, Price RW, Bestetti A, Turrini F, Caccia R, Gorelik L, Morelli MJ, Castagna A, Cinque P
• Cognitive impairment in people living with HIV: consensus recommendations for a new approach.
  Nature reviews. Neurology 2023 Nightingale S, Ances B, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Sandford C, Saylor D, Thomas KGF, Underwood J, Vera…
• Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
  Journal of virology 2023 Duran-Castells C, Llano A, Kawana-Tachikawa A, Prats A, Martinez-Zalacain I, Kobayashi-Ishihara M, Oriol-Tordera B, Peña R, Gálvez C, Silva-Arrieta S, Clotet B, Riveira-Muñoz E, Ballana E, Prado JG, …
• Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
  Nature microbiology 2023 Kincer LP, Joseph SB, Gilleece MM, Hauser BM, Sizemore S, Zhou S, Di Germanio C, Zetterberg H, Fuchs D, Deeks SG, Spudich S, Gisslen M, Price RW, Swanstrom R

Show all (212 more) Hide

• HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells.
  Pathogens & immunity 2023 Kincer LP, Schnell G, Swanstrom R, Miller MB, Spudich S, Eron JJ, Price RW, Joseph SB
• Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection.
  HIV medicine 2022 Le LT, Price RW, Gisslén M, Zetterberg H, Emu B, Fabre R, Christian P, Andersen S, Spudich S, Vassallo M
• A new approach to cognitive impairment in people with HIV.
  The lancet. HIV 2022 Nightingale S, Cinque P, Joska JA, Price RW, Underwood J, International HIV-Cognition Working Group
• Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Ulfhammer G, Edén A, Antinori A, Brew BJ, Calcagno A, Cinque P, De Zan V, Hagberg L, Lin A, Nilsson S, Oprea C, Pinnetti C, Spudich S, Trunfio M, Winston A, Price RW, Gisslén M
• Neuroimmunology of CNS HIV Infection: A Narrative Review.
  Frontiers in neurology 2022 Meyer AC, Njamnshi AK, Gisslen M, Price RW
• Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
  BMC neurology 2022 Anesten B, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslen M, Yilmaz A
• Blood biomarkers for HIV infection with focus on neurologic complications-A review.
  Acta neurologica Scandinavica 2022 Hagberg L, Edén A, Zetterberg H, Price RW, Gisslén M
• Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.
  Microbiology spectrum 2022 Cheng D, Luo Z, Fu X, Stephenson S, Di Germanio C, Norris PJ, Fuchs D, Ndhlovu LC, Li QZ, Zetterberg H, Gisslen M, Price RW, Peng S, Jiang W
• Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
  BMC neurology 2021 Anesten B, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M, Yilmaz A
• Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis.
  Journal of neurochemistry 2021 Edén A, Simrén J, Price RW, Zetterberg H, Gisslén M
• Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury.
  The Journal of infectious diseases 2021 Jiang W, Luo Z, Stephenson S, Li H, Di Germanio C, Norris PJ, Fuchs D, Zetterberg H, Gisslen M, Price RW
• Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
  PloS one 2021 Gisslen M, Keating SM, Spudich S, Arechiga V, Stephenson S, Zetterberg H, Di Germanio C, Blennow K, Fuchs D, Hagberg L, Norris PJ, Peterson J, Shacklett BL, Yiannoutsos CT, Price RW
• CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
  Neurology 2020 Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, Lindh M, Price RW, Zetterberg H, Gisslén M
• Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
  PloS one 2020 Hagberg L, Price RW, Zetterberg H, Fuchs D, Gisslén M
• Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
  Neurology 2020 Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K, Zetterberg H, Gisslén M
• Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.
  Journal of virus eradication 2020 Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ
• Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.
  Journal of acquired immune deficiency syndromes (1999) 2019 O'Meara T, Kong Y, Chiarella J, Price RW, Chaudhury R, Liu X, Spudich S, Robertson K, Emu B, Lu L
• Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
  PloS one 2019 Hermansson L, Yilmaz A, Price RW, Nilsson S, McCallister S, Makadzange T, Das M, Zetterberg H, Blennow K, Gisslen M
• Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
  AIDS (London, England) 2019 Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S
• Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
  AIDS (London, England) 2019 Spudich S, Peterson J, Fuchs D, Price RW, Gisslen M
• What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
  AIDS (London, England) 2019 Joseph SB, Trunfio M, Kincer LP, Calcagno A, Price RW
• Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK, Gisslén M, Spudich S, Menezes P, Robertson K, Archin N, Kashuba A, Eron JJ, Price RW, Swanstrom R
• Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive Impairment.
  Clinical and translational science 2019 Srinivas N, Joseph SB, Robertson K, Kincer LP, Menezes P, Adamson L, Schauer AP, Blake KH, White N, Sykes C, Luciw P, Eron JJ, Forrest A, Price RW, Spudich S, Swanstrom R, Kashuba ADM
• Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
  Current HIV/AIDS reports 2019 Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M
• Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
  Journal of neurovirology 2018 Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Gisslén M, Price RW, Valcour V, Ndhlovu LC
• Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Sanford R, Ances BM, Meyerhoff DJ, Price RW, Fuchs D, Zetterberg H, Spudich S, Collins DL
• CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Gisslén M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L, Spudich S, Fuchs D, Price RW, Zetterberg H
• Large Differences in Small RNA Composition Between Human Biofluids.
  Cell reports 2018 Godoy PM, Bhakta NR, Barczak AJ, Cakmak H, Fisher S, MacKenzie TC, Patel T, Price RW, Smith JF, Woodruff PG, Erle DJ
• Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV.
  JCI insight 2018 Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella J, Hafler DA, Spudich SS
• Brain MRI Features of CSF Human Immunodeficiency Virus Escape.
  Journal of neuroimaging : official journal of the American Society of Neuroimaging 2018 Narvid J, Callen A, Talbott J, Uzelac A, Dupont SM, Chow F, Price RW, Rehani B
• No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
  AIDS (London, England) 2018 Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A…
• Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
  The Journal of infectious diseases 2018 Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, Gisslén M
• HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
  PLoS medicine 2017 Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, …
• Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
  Expert review of molecular diagnostics 2017 Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, Spudich S, Underwood J, Zetterberg H, Gisslén M
• Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
  The Journal of infectious diseases 2017 Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, Zetterberg H, Price RW, Gisslén M, Spudich S
• Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.
  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Chow FC, Price RW, Hsue PY, Kim AS
• Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China.
  Journal of acquired immune deficiency syndromes (1999) 2017 Chow FC, Li Y, Hu Y, Chan J, Wang H, Xu W, Price RW, Sorond FA, Li T
• Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV.
  Neurology(R) neuroimmunology & neuroinflammation 2016 Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M
• Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA.
  Journal of virus eradication 2016 Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth Joseph S, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston …
• No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
  Virulence 2016 Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A, Cinque P, Nilsson S, Gisslén M
• Putamen volume and its clinical and neurological correlates in primary HIV infection.
  AIDS (London, England) 2016 Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM
• Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
  PloS one 2016 Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre SL, Gisslén M
• Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
  AIDS research and human retroviruses 2016 Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin BE, Ferre AL, Gillespie GM, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich SS, Shacklett BL
• Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].
  EBioMedicine 2016 Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H
• Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
  AIDS (London, England) 2016 Chow FC, Boscardin WJ, Mills C, Ko N, Carroll C, Price RW, Deeks S, Sorond FA, Hsue PY
• Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
  EBioMedicine 2015 Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H
• Phenotypic Correlates of HIV-1 Macrophage Tropism.
  Journal of virology 2015 Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping LH, Schnell G, Sturdevant CB, Kincer LP, Mallewa M, Heyderman RS, Rie AV, Cohen MS, Spudich S, Price RW, Montefiori DC, Swanstrom …
• Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
  Current HIV/AIDS reports 2015 Ferretti F, Gisslen M, Cinque P, Price RW
• Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
  HIV medicine 2015 Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study …
• Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
  PLoS pathogens 2015 Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S
• Cerebral white matter integrity during primary HIV infection.
  AIDS (London, England) 2015 Wright PW, Vaida FF, Fernández-de Thomas RJ, Rutlin J, Price RW, Lee E, Peterson J, Fuchs D, Shimony JS, Robertson KR, Walter R, Meyerhoff DJ, Spudich S, Ances BM
• Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.
  Journal of virus eradication 2015 Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, Liegler T, St John EP, Simen BB, Price RW, Spudich SS
• Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
  PloS one 2014 Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW
• Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
  Journal of neuroinflammation 2014 Suh J, Sinclair E, Peterson J, Lee E, Kyriakides TC, Li FY, Hagberg L, Fuchs D, Price RW, Gisslen M, Spudich S
• Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection.
  AIDS (London, England) 2014 Chow FC, Bacchetti P, Kim AS, Price RW, Hsue PY
• Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.
  Neurology 2014 Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S
• Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.
  AIDS (London, England) 2014 Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW
• Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.
  Journal of acquired immune deficiency syndromes (1999) 2014 Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, Fuchs D, Sinclair E, Price RW, Spudich S
• Longitudinal characterization of depression and mood states beginning in primary HIV infection.
  AIDS and behavior 2014 Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S
• Evolving character of chronic central nervous system HIV infection.
  Seminars in neurology 2014 Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, Gisslén M, Swanstrom R
• Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
  PloS one 2014 Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M
• Central nervous system HIV-1 infection.
  Handbook of clinical neurology 2014 Grill MF, Price RW
• An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.
  The Journal of infectious diseases 2013 Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S
• Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power.
  Neuroepidemiology 2013 Meyer AC, Boscardin WJ, Kwasa JK, Price RW
• Screening for HIV-associated peripheral neuropathy in resource-limited settings.
  Muscle & nerve 2013 Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC
• Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect.
  Journal of neurovirology 2013 Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR, INSIGHT SMART Study Group
• Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.
  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2013 Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, Gisslen M
• Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects.
  PloS one 2013 Ho EL, Ronquillo R, Altmeppen H, Spudich SS, Price RW, Sinclair E
• Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.
  Journal of neuroinflammation 2013 Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M
• Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.
  PLoS pathogens 2013 Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, …
• Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.
  AIDS (London, England) 2013 Dahl V, Peterson J, Spudich S, Lee E, Shacklett BL, Price RW, Palmer S
• Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
  The Journal of infectious diseases 2013 Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S
• Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
  Journal of neurology 2012 Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M
• Targeting chronic central nervous system HIV infection.
  Antiviral therapy 2012 Price RW, Swanstrom R
• Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
  AIDS (London, England) 2012 Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S
• Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration.
  The Journal of clinical investigation 2012 Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R…
• The cerebrospinal fluid proteome in HIV infection: change associated with disease severity.
  Clinical proteomics 2012 Angel TE, Jacobs JM, Spudich SS, Gritsenko MA, Fuchs D, Liegler T, Zetterberg H, Camp DG, Price RW, Smith RD
• Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.
  PloS one 2012 Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC
• The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
  BMC infectious diseases 2011 Gisslén M, Price RW, Nilsson S
• Antiretroviral drug treatment of CNS HIV-1 infection.
  The Journal of antimicrobial chemotherapy 2011 Yilmaz A, Price RW, Gisslén M
• Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.
  The Journal of infectious diseases 2011 Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E, Fuchs D, Palmer S, Price RW
• HIV-1 replication in the central nervous system occurs in two distinct cell types.
  PLoS pathogens 2011 Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R
• Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
  The Journal of infectious diseases 2011 Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW
• A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.
  Journal of neurovirology 2011 Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, …
• Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya.
  Journal of the neurological sciences 2011 Cettomai D, Kwasa J, Birbeck GL, Price RW, Bukusi EA, Meyer AC
• Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study.
  AIDS research and therapy 2011 Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW
• Impact of antiretroviral therapy on HIV-related brain injury.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011 Price RW
• Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing.
  PloS one 2010 Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC
• HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
  The Journal of infectious diseases 2010 Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M
• Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
  Neurology 2010 Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW, INSIGHT SMART Study Group
• Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.
  HIV clinical trials 2010 Lifson AR, INSIGHT Endpoint Review Committee Writing Group, Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, …
• Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.
  AIDS research and therapy 2010 Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D
• Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation.
  AIDS (London, England) 2010 Probasco JC, Deeks SG, Lee E, Hoh R, Hunt PW, Liegler T, Price RW, Spudich SS
• Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
  BMC neurology 2009 Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H
• Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
  Journal of virology 2009 Schnell G, Price RW, Swanstrom R, Spudich S
• Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum.
  Acta neurologica Belgica 2009 Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, Di Stefano AL, Cinque P
• Progressive multifocal leukoencephalopathy in HIV-1 infection.
  The Lancet. Infectious diseases 2009 Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW
• Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.
  PloS one 2009 Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW
• Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.
  AIDS (London, England) 2009 Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R
• Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.
  PLoS pathogens 2009 Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R
• Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.
  AIDS research and human retroviruses 2009 Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M
• Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
  Journal of virology 2009 Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI
• OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients.
  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2008 Buescher JL, Duan F, Sun J, Price RW, Ikezu T
• Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study.
  Neurology 2008 Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW
• Antiretroviral therapy and central nervous system HIV type 1 infection.
  The Journal of infectious diseases 2008 Price RW, Spudich S
• Determination of the underlying cause of death in three multicenter international HIV clinical trials.
  HIV clinical trials 2008 Lifson AR, INSIGHT Cause of Death Writing Group, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, …
• Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
  Journal of acquired immune deficiency syndromes (1999) 2008 Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW
• Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.
  Journal of acquired immune deficiency syndromes (1999) 2008 Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M
• Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.
  Antiviral therapy 2008 Price RW, Parham R, Kroll JL, Wring SA, Baker B, Sailstad J, Hoh R, Liegler T, Spudich S, Kuritzkes DR, Deeks SG
• Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.
  The Journal of infectious diseases 2007 Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M
• Biomarkers of HIV-1 CNS infection and injury.
  Neurology 2007 Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC
• Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
  Neurology 2007 Mellgren A, Price RW, Hagberg L, Rosengren L, Brew BJ, Gisslén M
• Updated research nosology for HIV-associated neurocognitive disorders.
  Neurology 2007 Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, …
• Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
  The Journal of infectious diseases 2007 Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L
• CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
  Journal of neurology 2007 Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M
• Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial.
  PLoS clinical trials 2007 Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, Romero C
• Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.
  Handbook of clinical neurology 2007 Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW
• Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
  The Journal of infectious diseases 2006 Spudich S, Lollo N, Liegler T, Deeks SG, Price RW
• Editorial comment: AIDS dementia complex in the current era.
  The AIDS reader 2006 Price RW
• Timed Gait test: normative data for the assessment of the AIDS dementia complex.
  Journal of clinical and experimental neuropsychology 2006 Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW
• Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.
  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2006 Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW
• Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.
  The Journal of infectious diseases 2006 Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG
• Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
  BMC infectious diseases 2005 Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW
• Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy.
  AIDS (London, England) 2005 Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM
• Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection.
  AIDS research and therapy 2005 Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW
• Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
  Journal of neuroimmunology 2005 Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW
• Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.
  Journal of acquired immune deficiency syndromes (1999) 2005 Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C
• T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection.
  Journal of acquired immune deficiency syndromes (1999) 2005 Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW
• Editorial comment: déjà vu--neurologic complications of HIV infection in the expanding epidemic.
  The AIDS reader 2005 Price RW, Robertson K
• HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
  The Journal of infectious diseases 2005 Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW
• Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
  Antiviral therapy 2005 Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M
• Neurological complications of HIV infection and AIDS: current and future perspectives.
  Journal of neurovirology 2005 Cinque P, Robertson K, Antinori A, Price RW
• Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.
  Journal of neuroimmunology 2004 Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P
• HIV-producing T cells in cerebrospinal fluid.
  Journal of acquired immune deficiency syndromes (1999) 2004 Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM
• Chemokine receptors, neural progenitor cells, and the AIDS dementia complex.
  The Journal of infectious diseases 2004 Kao AW, Price RW
• Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.
  The Journal of infectious diseases 2004 Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, Nixon DF, Price RW
• The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
  Annals of neurology 2004 Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N
• CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
  Brain : a journal of neurology 2004 Valle M, Price RW, Nilsson A, Heyes M, Verotta D
• Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
  Journal of neurovirology 2004 Price RW, Deeks SG
• Editorial comment: diagnosis of focal brain lesions--old lessons retaught.
  The AIDS reader 2003 Price RW
• A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
  The Journal of infectious diseases 2002 Aberg JA, Price RW, Heeren DM, Bredt B
• Screening for the AIDS dementia complex.
  The AIDS reader 2002 Price RW
• Cerebrospinal fluid response to structured treatment interruption after virological failure.
  AIDS (London, England) 2001 Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG
• HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
  AIDS (London, England) 2001 Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew B
• The two faces of HIV infection of cerebrospinal fluid.
  Trends in microbiology 2000 Price RW
• Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
  AIDS (London, England) 2000 Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI
• Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.
  AIDS (London, England) 1999 Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K
• Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.
  AIDS (London, England) 1999 Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW
• Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999 Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW
• Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.
  AIDS (London, England) 1998 Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD
• Neuropathy complicating diffuse infiltrative lymphocytosis.
  Lancet (London, England) 1998 Price RW
• Stable neurological function in subjects treated with 2'3'-dideoxyinosine.
  Journal of neurovirology 1997 Sidtis JJ, Dafni U, Slasor P, Hall C, Price RW, Kieburtz K, Tucker T, Clifford DB
• Neurological complications of HIV infection.
  Lancet (London, England) 1996 Price RW
• Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996 Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW
• Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.
  The Medical journal of Australia 1996 Brew BJ, Wesselingh SL, Gonzales M, Heyes MP, Price RW
• AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease.
  Cold Spring Harbor symposia on quantitative biology 1996 Price RW
• The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: introduction.
  Journal of neuro-AIDS 1996 Price RW
• AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations.
  Annals of neurology 1995 Brew BJ, Rosenblum M, Cronin K, Price RW
• AIDS dementia complex and HIV-1 brain infection: a pathogenetic framework for treatment and evaluation.
  Current topics in microbiology and immunology 1995 Price RW
• Management of AIDS dementia complex and HIV-1 infection of the nervous system.
  AIDS (London, England) 1995 Price RW
• Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex.
  Journal of neurology, neurosurgery, and psychiatry 1994 Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW
• Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
  Annals of neurology 1993 Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K
• Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
  Journal of virology 1992 Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, Hahn BH, Shaw GM
• Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection.
  Journal of neurochemistry 1992 Shaskan EG, Brew BJ, Rosenblum M, Thompson RM, Price RW
• Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
  Journal of neuroimmunology 1992 Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP
• Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients.
  Annals of neurology 1992 Shaskan EG, Thompson RM, Price RW
• Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
  AIDS (London, England) 1992 Brew BJ, Bhalla RB, Paul M, Sidtis JJ, Keilp JJ, Sadler AE, Gallardo H, McArthur JC, Schwartz MK, Price RW
• Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome.
  Human pathology 1992 Rosenblum MK, Brew BJ, Hahn B, Shaw G, Haase A, Maroushek S, Price RW
• Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
  Journal of virology 1992 Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L
• Pursuit eye movement dysfunction in HIV-1 seropositive individuals.
  Journal of psychiatry & neuroscience : JPN 1991 Sweeney JA, Brew BJ, Keilp JG, Sidtis JJ, Price RW
• Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
  Journal of virology 1991 Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH
• Herpes zoster myelitis.
  Brain : a journal of neurology 1991 Devinsky O, Cho ES, Petito CK, Price RW
• AIDS dementia complex and HIV-1 infection: a view from the clinic.
  Brain pathology (Zurich, Switzerland) 1991 Price RW, Sidtis JJ, Brew BJ
• HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.
  Neurology 1991 Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R
• Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
  Annals of neurology 1991 Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J
• Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.
  Advances in experimental medicine and biology 1991 Heyes MP, Brew B, Martin A, Markey SP, Price RW, Bhalla RB, Salazar A
• Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
  Annals of neurology 1990 Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW
• Early HIV-1 infection and the AIDS dementia complex.
  Neurology 1990 Sidtis JJ, Price RW
• Evaluation of the AIDS dementia complex in clinical trials.
  Journal of acquired immune deficiency syndromes 1990 Price RW, Sidtis JJ
• The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.
  Research publications - Association for Research in Nervous and Mental Disease 1990 Price RW, Brew BJ, Rosenblum M
• Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord.
  Neurology 1989 Rosenblum M, Scheck AC, Cronin K, Brew BJ, Khan A, Paul M, Price RW
• Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus.
  Neurology 1989 Brew BJ, Bhalla RB, Fleisher M, Paul M, Khan A, Schwartz MK, Price RW
• Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force.
  Neurology 1989 Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW
• AIDS dementia complex and primary HIV brain infection.
  Journal of neuroimmunology 1988 Brew BJ, Rosenblum M, Price RW
• The AIDS dementia complex.
  The Journal of infectious diseases 1988 Price RW, Brew BJ
• AIDS dementia complex.
  Journal of the Royal College of Physicians of London 1988 Brew BJ, Sidtis JJ, Rosenblum M, Price RW
• Management of the neurologic complications of HIV infection and AIDS.
  Infectious disease clinics of North America 1988 Price RW, Brew B
• Another retroviral disease of the nervous system: chronic progressive myelopathy due to HTLV-1.
  The New England journal of medicine 1988 Brew BJ, Price RW
• Neuropsychological characterization of the AIDS dementia complex: a preliminary report.
  AIDS (London, England) 1988 Tross S, Price RW, Navia B, Thaler HT, Gold J, Hirsch DA, Sidtis JJ
• The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
  Science (New York, N.Y.) 1988 Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P
• Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis.
  Annals of the New York Academy of Sciences 1988 Price RW, Brew B
• Pathogenetic implications of neuropathological findings in the AIDS dementia complex.
  Psychopharmacology bulletin 1988 Brew BJ, Rosenblum M, Price RW
• The management of the neurological complications of HIV infection and AIDS.
  AIDS (London, England) 1988 Aronow HA, Brew BJ, Price RW
• The metabolic pathology of the AIDS dementia complex.
  Annals of neurology 1987 Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW
• HIV antigen in the brains of patients with the AIDS dementia complex.
  Annals of neurology 1987 Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW
• 5-substituted 2'-fluoro-arabinonucleosides as potential antiviral agents.
  Nucleic acids symposium series 1987 Huang JT, Schinazi RF, Gadler H, Price RW, Su TL, Watanabe KA
• The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection.
  Archives of neurology 1987 Navia BA, Price RW
• Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.
  Journal of neuropathology and experimental neurology 1986 Petito CK, Cho ES, Lemann W, Navia BA, Price RW
• Confirmation of HTLV-III virus in cornea.
  American journal of ophthalmology 1986 Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price RW
• The AIDS dementia complex: I. Clinical features.
  Annals of neurology 1986 Navia BA, Jordan BD, Price RW
• The AIDS dementia complex: II. Neuropathology.
  Annals of neurology 1986 Navia BA, Cho ES, Petito CK, Price RW
• Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.
  Annals of neurology 1986 Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW
• AIDS encephalopathy.
  Neurologic clinics 1986 Price RW, Navia BA, Cho ES
• Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome.
  The New England journal of medicine 1985 Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW
• HTLV-III infection in brains of children and adults with AIDS encephalopathy.
  Science (New York, N.Y.) 1985 Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE
• Neurological syndromes complicating AIDS.
  Frontiers of radiation therapy and oncology 1985 Jordan BD, Navia BA, Petito C, Cho ES, Price RW
• Enhanced regional uptake of 2-deoxy-D-[14C]glucose in focal herpes simplex type 1 encephalitis: autoradiographic study in the rat.
  Neurology 1984 Saito Y, Price RW
• HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy.
  AIDS research 1984 Epstein LG, Sharer LR, Cho ES, Myenhofer M, Navia B, Price RW
• Progressive multifocal leukoencephalopathy: a burnt-out case.
  Annals of neurology 1983 Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D
• Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses.
  Journal of the neurological sciences 1982 Tsukamoto LF, Price RW
• Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.
  Neurology 1980 Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B
• Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
  The Journal of infectious diseases 1977 Walz MA, Price RW, Hayashi K, Katz BJ, Notkins AL